MWNA
IDYA icon

Marshall Wace North America’s IDEAYA Biosciences IDYA Stock Holding History

Marshall Wace North America’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-167,571
Closed -$3.94M – 1595
2021
Q1 		$3.94M Buy
167,571
+46,699
+39% +$902K 0.02% 629
2020
Q4 		$1.69M Buy
+120,872
New +$1.64M 0.01% 802

Other funds holding IDYA

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Marshall Wace North America's IDYA Position: Q2 2021 in Review

Marshall Wace North America sold out of IDEAYA Biosciences (IDYA) in Q2 2021, closing a stake of 167,571 shares — an estimated $3.94M sold.

Marshall Wace North America first reported a position in IDYA in Q4 2020 and held it in 2 quarters. The position peaked at $3.94M in Q1 2021. 84 funds tracked by Wall St. Rank hold IDYA as of Q2 2021.

  • Marshall Wace North America reported no remaining IDEAYA Biosciences position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 167,571 IDEAYA Biosciences shares in Q2 2021, an estimated $3.94M.
  • Marshall Wace North America first reported a position in IDEAYA Biosciences in Q4 2020 and held it in 2 quarters.
  • Marshall Wace North America's IDEAYA Biosciences position peaked at $3.94M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.